Osteoarthritis Trial, Recruiting NCT07016672 Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07016672
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been confirmed by MRI scan to have moderate to severe knee joint wear (grade III or IV) in one knee only
  • People whose knee pain is rated at least 3 out of 10 on a standard pain scale
  • People with a body mass index (BMI) under 35
  • People who are able to give their own informed consent to participate in the study
  • People who are covered by a social security or health insurance scheme

Who may not be able to join:

  • People who have taken anti-inflammatory medications (NSAIDs) or corticosteroid medicines in the 7 days before joining the trial (note: low-dose aspirin of 160 mg or less per day taken as a blood thinner is generally allowed)
  • People who have had a hyaluronic acid injection into the affected knee in the 2 months before joining
  • People who have had a PRP (platelet-rich plasma) injection into the affected knee within the past year
  • People who have had a corticosteroid injection into the affected knee within the past 5 months (note: corticosteroids given by other routes — such as skin cream, eye drops, or inhaler — affecting a different area of the body may be permitted)
  • People currently on blood-thinning (anticoagulant) medication that cannot be safely paused during the injection treatment period
  • People who have been diagnosed with any type of cancer in the last 3 years
  • People who are pregnant, in labour, or breastfeeding
  • People who are under legal guardianship or a court-ordered protection arrangement
  • People whose participation may interfere with the study results for any other reason, as judged by the trial doctor (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jean-Jacques Raymond, MD, Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

Phone: 0483772062

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Registry
ClinicalTrials.gov
Start date
18 September 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Functional impact

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov